NCT02531308 Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL) Status TERMINATED Phase PHASE2
NCT02526615 Effects of Rosiglitazone and Metformin on Metabolism in Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT02521753 Omega 3 Polyunsaturated Fatty Acids (PUFA) or Magnesium in Obese Polycystic Ovary Syndrome Patients Status TERMINATED Phase NA
NCT02519543 Treating Insulin Resistance as a Strategy to Improve Outcome in Refractory Bipolar Disorder Status COMPLETED Phase PHASE3
NCT02516085 Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin Status COMPLETED Phase PHASE1
NCT02515773 Metformin for Overweight & OBese ChILdren and Adolescents With BDS Treated With SGAs Status COMPLETED Phase PHASE4
NCT02514629 Testosterone, Metformin, or Both, for Hypogonadism in Obese Males Status COMPLETED Phase PHASE3
NCT02506790 Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT02506777 Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer. Status UNKNOWN Phase PHASE2
NCT02502344 Effect of Medical Interventions in Insulin Resistance on Prevalence of Abnormal Glucose Tolerance Status UNKNOWN Phase PHASE4
NCT02501850 The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a) Status UNKNOWN Phase PHASE4
NCT02501616 Effect of Dapagliflozine on Systemic and Renal Endothelial Function Status UNKNOWN Phase PHASE4
NCT02500147 Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS) Status TERMINATED Phase PHASE4
NCT02498522 Effect of Metformin on Early Pregnancy Loss in Pregnant Women With Polycystic Ovarian Syndrome Status COMPLETED Phase EARLY_PHASE1
NCT02497313 Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 Diabetes Status COMPLETED Phase NA
NCT02495103 Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma Status TERMINATED Phase PHASE1/PHASE2